dc.contributor.author |
Montero Menárguez, Julia |
dc.contributor.author |
Amat Samaranch, Victoria |
dc.contributor.author |
Puig Sanz, Lluís |
dc.contributor.author |
Ruiz Villaverde, Ricardo |
dc.contributor.author |
Arias Santiago, Salvador |
dc.contributor.author |
Larrea García, Mónica |
dc.contributor.author |
Ruiz Genao, Diana |
dc.contributor.author |
Ferran Farrés, Marta |
dc.contributor.author |
Schneller-Pavelescu, Luca |
dc.contributor.author |
Romero Ferreiro, Carmen |
dc.contributor.author |
Rivera Díaz. Raquel |
dc.date.accessioned |
2024-09-26T06:19:24Z |
dc.date.available |
2024-09-26T06:19:24Z |
dc.date.issued |
2024 |
dc.identifier.citation |
Montero-Menárguez J, Amat Samaranch V, Puig Sanz L, Ruiz-Villaverde R, Arias-Santiago S, Larrea García M, et al. Pityriasis rubra pilaris: a multicentric case series of 65 spanish patients. Actas Dermosifiliogr. 2024 Sep;115(8):t761-t5. DOI: 10.1016/j.ad.2024.02.019 |
dc.identifier.issn |
0001-7310 |
dc.identifier.uri |
http://hdl.handle.net/10230/61230 |
dc.description |
Article disponible en castellà: http://hdl.handle.net/10230/61229 |
dc.description.abstract |
Introduction: PRP is a rare entity of unknown etiopathogenesis. Lack of management guidelines makes it a challenge for clinicians. Objective: To add our experience to increase evidence about PRP. Methods: We performed a retrospective, descriptive and multicentric study of 65 patients with PRP, being the largest European case series of patients with PRP. Results: PRP was more frequent in male patients with an average age of 51 years, but erythrodermic forms presented in older patients (average age 61 years). Six (75%) paediatric patients and ten (60%) non-erythrodermic adults controlled their disease with topical corticosteroids. On the contrary, 26 (68%) erythrodermic patients required biologic therapy as last and effective therapy line requiring an average of 6.5 months to achieve complete response. Conclusion: Our study showed a statistical difference in terms of outcome and response to treatment between children or patients with limited disease and patients who develop erythroderma. |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Elsevier |
dc.relation.ispartof |
Actas Dermosifiliogr. 2024 Sep;115(8):t761-t5 |
dc.rights |
© 2024 AEDV. Published by Elsevier España, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
dc.rights.uri |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.title |
Pityriasis rubra pilaris: a multicentric case series of 65 spanish patients |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1016/j.ad.2024.02.019 |
dc.subject.keyword |
Pityriasis rubra pilaris |
dc.subject.keyword |
Biologic agents |
dc.subject.keyword |
Erythroderma |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/publishedVersion |